Document Detail


Relationship between CHADS2 score and ischemic stroke during rhythm control therapy for paroxysmal atrial fibrillation.
MedLine Citation:
PMID:  20145347     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The CHADS2 score has been proposed for stratifying patients with nonvalvular atrial fibrillation (NVAF) according to the risk of thromboembolism in the AHA/ACC/ESC guidelines. However, there is little information about its usefulness for predicting the long-term risk of ischemic stroke in Japanese patients with paroxysmal AF. We retrospectively evaluated the incidence of ischemic stroke and the efficacy of anticoagulant therapy in paroxysmal AF patients on rhythm control therapy who were stratified by their CHADS2 score. The subjects were 334 NVAF atients (229 men and 105 women, mean age, 68 +/- 12 years, mean follow-up period, 60 +/- 35 months) who were categorized into low risk (score 0), moderate risk (1 or 2), and high risk (3 or more) groups for thromboembolism. The low, moderate, and high risk groups accounted for 34%, 50%, and 16% of the patients, respectively. Among 257 patients without warfarin therapy, the annual rate of symptomatic ischemic stroke was 0.6% in the score 0 group, 0.5% in the score 1 group, 3.1% in the score 2 group, and 9.6% in the score 3 or more group. Among 77 patients treated with warfarin (target PT-INR: 1.6-3.0), the stroke rate was 0% in the score 0 group, 0% in the score 1 group, 1.4% in the score 2 group, and 6.6% in the score 3 or more group. The annual rate of ischemic stroke was 0.88% in patients treated with warfarin versus 2.67% in those without warfarin, or a decrease in risk of 68% with warfarin (P < 0.01). In Japanese patients with paroxysmal AF, the CHADS2 score is useful for predicting the risk of ischemic stroke. Anticoagulant therapy is needed to prevent ischemic stroke in patients with paroxysmal AF, especially those who have a CHADS2 score of 2 or more.
Authors:
Takashi Komatsu; Hideaki Tachibana; Yoshihiro Sato; Masato Ozawa; Fusanori Kunugida; Makoto Orii; Motoyuki Nakamura
Related Documents :
20885017 - Influence of vitamin c on markers of oxidative stress in the earliest period of ischemi...
12817107 - Mortality and recovery after stroke in the gambia.
17114877 - Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ische...
6238437 - Long-term results of direct vertebral artery operations.
24673617 - 'short-term treatment with methotrexate does not affect microvascular endothelial funct...
22674157 - Comparison between lumbar and thoracic epidural morphine for severe isolated blunt ches...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International heart journal     Volume:  51     ISSN:  1349-2365     ISO Abbreviation:  Int Heart J     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2010-02-10     Completed Date:  2010-03-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101244240     Medline TA:  Int Heart J     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  24-9     Citation Subset:  IM    
Affiliation:
Division of Cardiology, Department of Internal Medicine, Iwate Medical University School of Medicine.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Anticoagulants / therapeutic use
Atrial Fibrillation / complications,  drug therapy,  epidemiology*
Brain Infarction / epidemiology*,  etiology
Cardiac Pacing, Artificial
Female
Humans
Japan / epidemiology
Male
Middle Aged
Retrospective Studies
Severity of Illness Index*
Warfarin / therapeutic use
Chemical
Reg. No./Substance:
0/Anticoagulants; 81-81-2/Warfarin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Right Ventricular Histological Substrate and Conduction Delay in Patients With Brugada Syndrome.
Next Document:  High Homocysteine Levels Predict the Recurrence of Atrial Fibrillation After Successful Electrical C...